Table 1.
Demographic and clinical characteristics of patients with GEP-NETs
| Characteristic | N | Percentage |
|---|---|---|
| Age, median (range), years | 52 (14–76) | |
| Gender | ||
| Female | 71 | 51.1% |
| Male | 68 | 48.9% |
| Functionality | ||
| No | 121 | 87.1% |
| Yes | 18 | 12.9% |
| Carcinoid syndrome | 8 | 5.8% |
| Cushing syndrome | 1 | 0.7% |
| Insulinoma | 2 | 1.4% |
| Glucagonoma | 1 | 0.7% |
| Gastrinoma | 6 | 4.3% |
| Primary sites | ||
| Pancreas | 32 | 23.0% |
| Stomach | 15 | 10.8% |
| Duodenum | 12 | 8.6% |
| Small intestine | 14 | 10.1% |
| Colon | 3 | 2.2% |
| Rectum | 63 | 45.3% |
| Grade | ||
| G1 | 26 | 18.7% |
| G2 | 101 | 72.7% |
| G3 | 12 | 8.6% |
| AJCC stage | ||
| I | 17 | 12.2% |
| II | 3 | 2.2% |
| III | 2 | 1.4% |
| IV | 117 | 84.2% |
| Metastatic sites | ||
| Lymph nodes | 83 | 59.7% |
| Liver | 111 | 79.9% |
| Bone | 35 | 25.2% |
| Lung | 6 | 4.3% |
| Others | 26 | 18.7% |